Sensitive biomarkers are crucial because they can detect changes at low levels of exposure, often before clinical symptoms arise. This early detection enables timely intervention and prevention of adverse health effects. They also help in understanding the mechanisms of action of toxic substances, guiding the development of safer chemicals and therapeutic strategies.
